多指标联合预测院外心脏骤停患者自主循环恢复的临床应用价值

程松, 李海山. 多指标联合预测院外心脏骤停患者自主循环恢复的临床应用价值[J]. 临床急诊杂志, 2023, 24(12): 624-630. doi: 10.13201/j.issn.1009-5918.2023.12.02
引用本文: 程松, 李海山. 多指标联合预测院外心脏骤停患者自主循环恢复的临床应用价值[J]. 临床急诊杂志, 2023, 24(12): 624-630. doi: 10.13201/j.issn.1009-5918.2023.12.02
CHENG Song, LI Haishan. The clinical application value of combined prediction model for ROSC in patients with OHCA[J]. J Clin Emerg, 2023, 24(12): 624-630. doi: 10.13201/j.issn.1009-5918.2023.12.02
Citation: CHENG Song, LI Haishan. The clinical application value of combined prediction model for ROSC in patients with OHCA[J]. J Clin Emerg, 2023, 24(12): 624-630. doi: 10.13201/j.issn.1009-5918.2023.12.02

多指标联合预测院外心脏骤停患者自主循环恢复的临床应用价值

详细信息

The clinical application value of combined prediction model for ROSC in patients with OHCA

More Information
  • 目的 探索多指标联合预测模型对院外心脏骤停(out-of-hospital cardiac arrest,OHCA)患者自主循环恢复(return of spontaneous circulation,ROSC)的临床应用价值。方法 选择2019年1月-2021年12月在合肥市第二人民医院急诊科救治的843例OHCA患者为研究对象,根据复苏结果分为ROSC组210例(24.9%),非ROSC组633例(75.1%)。采用单因素分析和二元logistic回归分析筛选独立影响因素,构建列线图,采用校准图、临床决策曲线评估模型,并对模型进行内部验证。结果 无血流时间越短、初始心律为室颤和无脉电活动、有旁观者心肺复苏、除颤次数≤1次、肾上腺素总使用剂量越小、强心药物的使用、CPR时间 < 30 min的OHCA患者更易获得自主循环恢复,由此构建的联合预测模型曲线下面积(area under curve, AUC)为0.876,内部验证校准AUC值为0.876,校准曲线接近预测曲线,决策曲线分析阈概率为8%~100%,表明有良好临床获益。结论 本研究构建的联合预测模型,对OHCA自主循环恢复的预测有一定的临床价值,有助于对OHCA患者进行早期评估及治疗过程中诊疗计划的制定。
  • 加载中
  • 图 1  OHCA患者入组流程图

    图 2  OHCA患者ROSC多指标预测模型的列线图

    图 3  OHCA患者ROSC多指标预测模型的ROC曲线

    图 4  Bootstrap重抽样法内部验证联合预测模型的校准曲线图

    图 5  预测ROSC的决策曲线分析图

    表 1  ROSC组和非ROSC组一般资料对比 例(%),X±S

    资料 ROSC组(210例) 非ROSC组(633例) t/χ2 P
    性别 7.771 0.005
      男 128(61.0) 451(71.2)
      女 82(39.0) 182(28.8)
    年龄/岁 1.925 0.750
       < 60 75(35.7) 233(36.8)
      60~70 32(15.2) 105(16.6)
      >70~80 48(22.9) 118(18.6)
      >80~90 45(21.4) 148(23.4)
      >90 10(0.5) 29(4.6)
    无血流时间 10.52±1.62 11.21±1.97 -5.041 < 0.001
    初始心律 127.618 < 0.001
      室颤/室速 67(31.9) 32(5.1)
      无脉性电活动 36(17.1) 63(10.0)
      心脏停搏 107(60.0) 538(85.0)
    旁观者 15.323 < 0.001
      有 177(84.3) 447(70.6)
      无 33(15.7) 186(29.4)
    旁观者心肺复苏 43.681 < 0.001
      有 55(26.2) 54(8.5)
      无 155(73.8) 579(91.5)
    病因 7.182 0.066
      心源性 176(83.8) 504(79.6)
      创伤性 14(6.7) 83(13.1)
      低氧 10(4.8) 25(3.9)
      其他 10(4.8) 21(3.3)
    既往基础疾病
      心脏病 34(16.2) 71(11.2) 3.578 0.059
      高血压 29(13.8) 60(9.5) 3.132 0.077
      肿瘤晚期 7(3.3) 34(5.4) 1.415 0.234
      脑卒中 10(4.8) 21(3.3) 0.929 0.335
      肺部疾病 9(4.3) 23(3.6) 0.184 0.668
      糖尿病 13(6.2) 28(4.4) 1.064 0.302
      其他 6(2.9) 18(2.8) < 0.001 0.992
    地点 38.449 < 0.001
      疗养院 10(4.8) 16(2.5)
      工作地点 7(8.1) 15(2.4)
      医生办公室 50(23.8) 60(9.5)
      公共场所 47(22.4) 186(29.4)
      家 85(40.5) 279(44.1)
      其他 11(5.2) 77(12.2)
    电除颤次数/次 136.943 < 0.001
      0 117(55.7) 518(81.8)
      1 76(36.2) 32(5.1)
      >1 17(8.1) 83(13.1)
    肾上腺素使用剂量/mg 237.105 < 0.001
      0~2 63(30.0) 23(3.6)
      >2~4 60(28.6) 41(6.5)
      >4~6 38(18.1) 109(17.2)
      >6~8 23(11.0) 152(24.0)
      >8 26(12.4) 308(48.7)
    胺碘酮使用 1.606 0.205
      有 7(3.3) 35(5.5)
      无 203(96.7) 598(94.5)
    强心药物使用a) 53.240 < 0.001
      有 59(28.1) 53(8.4)
      无 151(71.9) 580(91.6)
    纠酸药物使用 0.909 0.340
      有 68(32.4) 183(28.9)
      无 142(67.6) 450(71.1)
    入院时血压/mmHgb) 17.126 < 0.001
       < 90 40(19.0) 89(14.1)
      正在心肺复苏 145(69.0) 513(81.0)
      >90 25(11.9) 31(4.9)
    CPR时间分层/min 259.827 < 0.001
       < 30 171(81.4) 127(20.1)
      ≥30 39(18.6) 506(79.9)
    注:a)强心药物包括多巴胺、多巴酚丁胺;b)1 mmHg=0.133 kPa。
    下载: 导出CSV

    表 2  二元logistic回归分析结果

    因素 β SE P OR 95%CI
    无血流时间 -0.135 0.062 0.030 0.874 0.774~0.987
    初始心律
      心脏停搏 0.034
      室颤/室速 0.607 0.664 0.361 1.834 0.499~6.745
      无脉电活动 1.130 0.451 0.012 3.094 1.278~7.494
    有旁观者心肺复苏 1.057 0.467 0.023 2.878 1.153~7.182
    除颤次数/次
      0 0.005
      1 1.567 0.512 0.002 4.791 1.758~13.056
      >1 -0.199 0.445 0.654 0.820 0.343~1.959
    肾上腺素剂量/mg
      0~2 2.439 0.426 < 0.001 11.457 4.968~26.421
      >2~4 2.174 0.386 < 0.001 8.792 4.124~18.741
      >4~6 1.439 0.346 < 0.001 4.215 2.140~8.302
      >6~8 1.367 0.340 < 0.001 3.922 2.140~7.643
      >8 < 0.001
    使用强心药物 1.652 0.360 < 0.001 5.220 2.013~10.562
    CPR时间 < 30min 2.166 0.249 < 0.001 8.726 5.361~14.203
    常量 -2.564 0.716 < 0.001 0.077
    下载: 导出CSV

    表 3  分数X的计算

    因素 分数X 分类
    -2.5 常数
    无血流时间 -0.1 每分钟
    初始心律 +0.6 室颤/室速
    +1.1 无脉性电活动
    旁观者心肺复苏 +1.1
    除颤次数 +1.6 1次
    -0.2 >1次
    肾上腺素使用剂量 +2.4 0~2 mg
    +2.1 >2~4 mg
    +1.4 >4~6 mg
    +1.4 >6~8 mg
    强心药物应用 -1.7
    CPR时间 +2.2 < 30 min
    下载: 导出CSV

    表 4  OHCA患者ROSC的各独立预测指标及联合预测模型的预测效果比较

    指标 曲线下面积 截断值 灵敏度 特异度 阳性预测值/% 阴性预测值/%
    无血流时间 0.611 12.05 min 0.379 0.867 31.7 89.6
    初始心律 0.682 0.490 0.850 52.0 83.4
    旁观者心肺复苏 0.588 0.355 0.915 50.5 78.9
    除颤次数 0.609 0.443 0.818 44.7 81.6
    肾上腺素 0.804 0.767 0.727 48.2 90.4
    强心药物的使用 0.599 0.281 0.916 52.7 79.3
    CPR时间分层 0.807 0.814 0.800 57.4 92.8
    联合预测模型 0.876 0.791 0.916 75.8 92.9
    下载: 导出CSV
  • [1]

    Kiguchi T, Okubo M, Nishiyama C, et al. Out-of-hospital cardiac arrest across the World: First report from the International Liaison Committee on Resuscitation(ILCOR)[J]. Resuscitation, 2020, 152: 39-49. doi: 10.1016/j.resuscitation.2020.02.044

    [2]

    Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association[J]. Circulation, 2020, 141(9): e139-e596.

    [3]

    Grasner JT, Herlitz J, Tjelmeland IBM, et al. European Resuscitation Council Guidelines 2021: Epidemiology of cardiac arrest in Europe[J]. Resuscitation, 2021, 161: 61-79. doi: 10.1016/j.resuscitation.2021.02.007

    [4]

    Xie X, Zheng J, Zheng W, et al. Efforts to Improve Survival Outcomes of Out-of-Hospital Cardiac Arrest in China: BASIC-OHCA[J]. Circ Cardiovasc Qual Outcomes, 2023, 16(2): e008856.

    [5]

    Gamberini L, Mazzoli C A, Allegri D, et al. Factors influencing prehospital physicians' decisions to initiate advanced resuscitation for asystolic out-of-hospital cardiac arrest patients[J]. Resuscitation, 2022, 177: 19-27. doi: 10.1016/j.resuscitation.2022.06.015

    [6]

    Seewald S, Wnent J, Lefering R, et al. CaRdiac Arrest Survival Score(CRASS)-A tool to predict good neurological outcome after out-of-hospital cardiac arrest[J]. Resuscitation, 2020, 146: 66-73. doi: 10.1016/j.resuscitation.2019.10.036

    [7]

    Grasner JT, Meybohm P, Lefering R, et al. ROSC after cardiac arrest--the RACA score to predict outcome after out-of-hospital cardiac arrest[J]. Eur Heart J, 2011, 32(13): 1649-1656. doi: 10.1093/eurheartj/ehr107

    [8]

    Amnuaypattanapon K, Thanachartwet V, Desakorn V, et al. Predictive model of return of spontaneous circulation among patients with out-of-hospital cardiac arrest in Thailand: The WATCH-CPR Score[J]. Int J Clin Pract, 2020, 74(7): e13502.

    [9]

    Huabbangyang T, Silakoon A, Papukdee P, et al. Sustained Return of Spontaneous Circulation Following Out-of-Hospital Cardiac Arrest; Developing a Predictive Model Based on Multivariate Analysis[J]. Arch Acad Emerg Med, 2023, 11(1): e33.

    [10]

    Adnet F, Triba M N, Borron SW, et al. Cardiopulmonary resuscitation duration and survival in out-of-hospital cardiac arrest patients[J]. Resuscitation, 2017, 111: 74-81. doi: 10.1016/j.resuscitation.2016.11.024

    [11]

    张华忠, 梅勇, 吕金如, 等. 40例体外膜肺氧合辅助心肺复苏治疗成人院外心脏骤停的回顾性分析[J]. 中华急诊医学杂志, 2022, 31(12): 1618-1622.

    [12]

    朱瑞秋, 叶志钢, 刘长智, 等. 区域性复苏中心体外心肺复苏治疗难治性心脏骤停的回顾性分析[J]. 中国急救医学, 2023, 43(8): 643-646. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJJY202308010.htm

    [13]

    武小娟, 孟舰, 刘红新, 等. 心脏骤停心肺复苏术中"生存链"实施现状及患者预后因素分析[J]. 临床急诊杂志, 2022, 23(3): 198-203. https://lcjz.whuhzzs.com/article/doi/10.13201/j.issn.1009-5918.2022.03.007

    [14]

    Tanguay-Rioux X, Grunau B, Neumar R, et al. Is initial rhythm in OHCA a predictor of preceding no flow time? Implications for bystander response and ECPR candidacy evaluation[J]. Resuscitation, 2018, 128: 88-92. doi: 10.1016/j.resuscitation.2018.05.002

    [15]

    Callans DJ. Out-of-hospital cardiac arrest--the solution is shocking[J]. N Engl J Med, 2004, 351(7): 632-634. doi: 10.1056/NEJMp048174

    [16]

    Hagihara A, Onozuka D, Ono J, et al. Interaction of defibrillation waveform with the time to defibrillation or the number of defibrillation attempts on survival from out-of-hospital cardiac arrest[J]. Resuscitation, 2018, 122: 54-60. doi: 10.1016/j.resuscitation.2017.11.053

    [17]

    Tateishi K, Saito Y, Kitahara H, et al. Impact of number of defibrillation attempts on neurologically favourable survival rate in patients with Out-of-Hospital cardiac arrest[J]. Resuscitation, 2023, 186: 109779. doi: 10.1016/j.resuscitation.2023.109779

    [18]

    李博, 王旭垠, 房磊, 等. 心脏骤停后综合征患者72 h死亡危险因素分析[J]. 宁夏医学杂志, 2021, 43(7): 632-633. https://www.cnki.com.cn/Article/CJFDTOTAL-NXYX202107022.htm

    [19]

    Holmen J, Hollenberg J, Claesson A, et al. Survival in ventricular fibrillation with emphasis on the number of defibrillations in relation to other factors at resuscitation[J]. Resuscitation, 2017, 113: 33-38. doi: 10.1016/j.resuscitation.2017.01.006

    [20]

    Ong ME, Shin SD, De Souza NN, et al. Outcomes for out-of-hospital cardiac arrests across 7 countries in Asia: The Pan Asian Resuscitation Outcomes Study(PAROS)[J]. Resuscitation, 2015, 96: 100-108.

    [21]

    Cournoyer A, Grunau B, Cheskes S, et al. Clinical outcomes following out-of-hospital cardiac arrest: The minute-by-minute impact of bystander cardiopulmonary resuscitation[J]. Resuscitation, 2023, 185: 109693. doi: 10.1016/j.resuscitation.2023.109693

    [22]

    Song J, Guo W, Lu X, et al. The effect of bystander cardiopulmonary resuscitation on the survival of out-of-hospital cardiac arrests: a systematic review and meta-analysis[J]. Scand J Trauma Resusc Emerg Med, 2018, 26(1): 86. doi: 10.1186/s13049-018-0552-8

    [23]

    Zhou G, Wang Y, Sun Z, et al. Survival outcome among patients with out-of-hospital cardiac arrest who received cardiopulmonary resuscitation in China: a systematic review and meta-analysis[J]. Eur J Med Res, 2023, 28(1): 8. doi: 10.1186/s40001-022-00955-x

    [24]

    Perkins GD, Ji C, Deakin CD, et al. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest[J]. N Engl J Med, 2018, 379(8): 711-721. doi: 10.1056/NEJMoa1806842

    [25]

    Lin S, Callaway CW, Shah PS, et al. Adrenaline for out-of-hospital cardiac arrest resuscitation: a systematic review and meta-analysis of randomized controlled trials[J]. Resuscitation, 2014, 85(6): 732-740. doi: 10.1016/j.resuscitation.2014.03.008

    [26]

    王立祥, 孟庆义, 余涛. 2016中国心肺复苏专家共识[J]. 中华危重病急救医学, 2016, 28(12): 1059-1079. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJJY202308002.htm

    [27]

    兰超, 王超, 吕震宇, 等. 多巴胺对兔心肺复苏早期血流动力学及脑氧代谢的影响[J]. 中华急诊医学杂志, 2018, 27(1): 51-56. https://cdmd.cnki.com.cn/Article/CDMD-10459-1018109828.htm

  • 加载中

(5)

(4)

计量
  • 文章访问数:  312
  • PDF下载数:  87
  • 施引文献:  0
出版历程
收稿日期:  2023-08-14
刊出日期:  2023-12-10

目录